Search - tctmd.com

Displaying 101 - 120 of 1177

Sort: Relevancy | Date

Animal Study Considerations

Presentation TCT 2024

Animal Study Considerations

Presenter: Natalie Miller

October 27, 2024

Biocompatibility Evaluation Considerations

Presentation TCT 2024

Biocompatibility Evaluation Considerations

Presenter: Girish Kumar

October 27, 2024

Considerations in Particulate Testing

Presentation TCT 2024

Considerations in Particulate Testing

Presenter: Samuel Raben

October 27, 2024

Considerations in Simulated Use Testing

Presentation TCT 2024

Considerations in Simulated Use Testing

Presenter: Kevin Soucy

October 27, 2024

What’s Going to Be Big at TCT 2024?

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

News Daily News

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

October 15, 2024

AHA Statement Outlines Cardiac Contributions to Brain Health

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

October 11, 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

News Daily News

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

October 10, 2024

Incorrect Arm Positions Overestimate Blood Pressure Measurements

News Daily News

Incorrect Arm Positions Overestimate Blood Pressure Measurements

Michael O'Riordan

October 08, 2024

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

News Daily News

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Michael O'Riordan

October 03, 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

October 02, 2024

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

News Daily News

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

October 02, 2024

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

News Daily News

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

September 26, 2024

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

Little Pre- and Postmarket Testing for Most Recalled CV Devices

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

Access to Cardiac PET Limited in Many Parts of the US

News Daily News

Access to Cardiac PET Limited in Many Parts of the US

September 13, 2024

Statins Are Cost-effective in the Elderly

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.